7 Pharma Firms Eye Generic Semaglutide, Prices May Fall 50% Post Patent Expiry: Report Parthika Patel27 Feb 2026 7:40 PM ISTNew Delhi: Prices of widely used weight-loss drugs such as Wegovy and Ozempic are expected to drop significantly in India after the semaglutide patent...
Dr Reddy's Prepares Generic Semaglutide Entry Under Brand Obeda, Targets 60% Price Cut: Report Parthika Patel26 Feb 2026 10:01 PM ISTMumbai: Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name...
USFDA Accepts Dr Reddy's BLA for Interchangeable Orencia Biosimilar Parthika Patel21 Feb 2026 1:00 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd. has received acceptance from the U.S. Food and Drug Administration to review its 351(k) Biologics License...
Dr Reddy's Acquires Progynova, Cyclo-Progynova Brands from Mercury Pharma sheeba farhat19 Feb 2026 9:35 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd. has announced the acquisition of the trademarks for specialty brands Progynova and Cyclo-Progynova, along...
UP Pharma Conclave 1.0: CM Yogi Promises Safety, Stability, Speed to Global Pharma Investors sheeba farhat4 Feb 2026 8:16 PM ISTLucknow: Chief Minister Yogi Adityanath on Tuesday inaugurated the global congregation of investors and entrepreneurs 'Uttar Pradesh Pharma Conclave...
Dr Reddy's Russia Arm Slapped Rs 2.45 Cr VAT Penalty Parthika Patel29 Jan 2026 11:33 PM ISTNew Delhi: Drug major Dr. Reddy's Laboratories Limited's step-down wholly owned subsidiary, Dr. Reddy's Laboratories LLC, Russia, has received a tax...
Dr Reddy's Foils Email Spoofing Scam, Rs 2.16 Cr Recovered by Bengaluru Police Parthika Patel23 Jan 2026 4:25 PM ISTBengaluru: Bengaluru City Police have dismantled an international email spoofing racket and recovered Rs 2.16 crore that had been fraudulently...
USFDA Issues Post-Application Action Letter to Dr Reddy's Biologics Unit Farhat Nasim10 Jan 2026 10:29 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd has received a Post-Application Action Letter (PAAL) from the United States Food and Drug Administration...
Dr Reddy's Denosumab Biosimilar AVT03 Faces USFDA Setback After Plant Inspection Farhat Nasim1 Jan 2026 5:54 PM ISTNew Delhi: Drug major Dr Reddy's Laboratories Limited's wholly owned subsidiary, Dr. Reddy's Laboratories SA, Switzerland, has received a Complete...
Cybercriminals Trick Dr Reddy's Finance Team, Divert Rs 2.16 Crore Payment Parthika Patel10 Nov 2025 7:19 PM ISTBengaluru: In a major cybercrime incident, Dr Reddy's Laboratories Ltd has been duped of Rs 2.16 crore after hackers impersonated a senior executive...
Natco vs Novo Nordisk: Delhi High Court Directs Mediation in Wegovy Patent Dispute Farhat Nasim21 Aug 2025 9:26 PM ISTNew Delhi: Hyderabad-based Natco Pharma has filed a lawsuit against Danish drugmaker Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy...
Dr Reddy's Secures CDSCO Panel Approval to Import, Market Olutasidenib for AML Susmita Roy17 Aug 2025 4:00 PM ISTNew Delhi: In a significant development, the pharmaceutical major, Dr. Reddy's Laboratories, has got the go-ahead from the Subject Expert Committee...
